Geographic Information and Customer Concentration (Tables)

12 Months Ended

Dec. 31, 2012

GEOGRAPHIC INFORMATION [Abstract]

Schedule of revenue by customer and product

The following table shows selected information by geographic area:

	Revenues		Profit (Loss) from Operations			Identifiable Assets
As of and for the year ended December 31, 2012-
United States	$	8,566,725	$	(3,784,230	)	$	31,967,418
Switzerland	17,261,652		6,593,738			1,189,183
Other	—		—			3,781,080
Subtotal International	17,261,652		6,593,738			4,970,263
Total	$	25,828,377	$	2,809,508		$	36,937,681
As of and for the year ended December 31, 2011-
United States	$	28,420,480	$	17,761,438		$	26,588,480
Switzerland	14,641,541		5,167,424			5,149,384
Other	—		—			4,344,722
Subtotal International	14,641,541		5,167,424			9,494,106
Total	$	43,062,021	$	22,928,862		$	36,082,586
As of and for the year ended December 31, 2010-
United States	$	33,281,893	$	(5,837,836	)	$	23,344,803
Switzerland	10,353,058		7,011,629			4,187,637
Other	2,041,346		—			2,326,402
Subtotal International	12,394,404		7,011,629			6,514,039
Total	$	45,676,297	$	1,173,793		$	29,858,842

Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]

The following table presents information about Columbia’s revenues by customer, including royalty and license revenue for the three years ended December 31:

	2012		2011			2010
Merck Serono	17,215,126		14,627,491			10,353,058
Actavis	8,061,253		27,826,678			20,122,930
Lil' Drug Store Products, Inc.	505,473		445,149			3,787,133
Cardinal Healthcare	—		232,470			3,729,885
McKesson	—		229,887			3,130,158
All others (none over 5%)	46,525		(299,654		)	4,553,133
Total	$	25,828,377	$	43,062,021		$	45,676,297

Revenue from External Customers by Products and Services [Table Text Block]

The following table sets forth the breakdown of the Company's consolidated net revenues, consisting of sales, royalty and licensing income, by revenue source for each product accounting for 10% or more of consolidated revenues in any of the three years ended December 31:

	2012		2011			2010
CRINONE®	$	22,045,871	$	17,807,014		$	21,249,096
Actavis Royalties and Deferred Revenue Recognition	3,079,379		24,625,204			18,118,833
RepHresh®	—		—			1,971,981
Replens®	—		662			1,815,365
STRIANT®	84,602		454,453			1,293,416
PROCHIEVE®	100,000		(284,521		)	716,872
Other	518,525		459,209			510,734
Total	$	25,828,377	$	43,062,021		$	45,676,297